We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$690M
AUM Growth
+$23M
Cap. Flow
+$5.86M
Cap. Flow %
0.85%
Top 10 Hldgs %
28.08%
Holding
326
New
10
Increased
96
Reduced
106
Closed
15

Top Sells

Rank Stock Value
1
GGP
GGP Inc.
GGP
+$1.11M
2
LOW icon
Lowe's Companies
LOW
+$944K
3
KMI icon
Kinder Morgan
KMI
+$758K
4
WMT icon
Walmart Inc
WMT
+$724K
5
GE icon
GE Aerospace
GE
+$723K

Sector Composition

Rank Sector Weight
1 Healthcare 21.83%
2 Industrials 14.84%
3 Consumer Staples 10.44%
4 Financials 9.56%
5 Technology 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
26
Invesco QQQ Trust
QQQ
$450B
$6.36M 0.92%
53,656
+12,153
+29% +$1.43M
XOM icon
27
ExxonMobil
XOM
$651B
$6.22M 0.9%
68,868
-229
-0.3% -$20K
BA icon
28
Boeing
BA
$165B
$5.95M 0.86%
38,232
-192
-0.5% -$28K
WMT icon
29
Walmart Inc
WMT
$871B
$5.86M 0.85%
254,529
-31,014
-11% -$724K
PFE icon
30
Pfizer
PFE
$140B
$5.76M 0.83%
186,859
-12,596
-6% -$385K
IBM icon
31
IBM
IBM
$202B
$5.67M 0.82%
35,751
+6,631
+23% +$1.01M
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.25B
$5.2M 0.75%
180,280
+14,990
+9% +$397K
RTX icon
33
RTX Corp
RTX
$287B
$5.2M 0.75%
75,362
+412
+0.5% +$27.3K
LOW icon
34
Lowe's Companies
LOW
$116B
$5.14M 0.75%
72,291
-13,339
-16% -$944K
GILD icon
35
Gilead Sciences
GILD
$161B
$4.84M 0.7%
67,580
-900
-1% -$66.9K
EPD icon
36
Enterprise Products Partners
EPD
$83.8B
$4.82M 0.7%
178,262
+6,424
+4% +$167K
MRK icon
37
Merck
MRK
$324B
$4.76M 0.69%
84,824
+2,096
+3% +$123K
TMO icon
38
Thermo Fisher Scientific
TMO
$211B
$4.73M 0.69%
33,548
-611
-2% -$90.1K
CVX icon
39
Chevron
CVX
$388B
$4.71M 0.68%
40,041
+3
+0% +$327
EOG icon
40
EOG Resources
EOG
$78B
$4.69M 0.68%
46,375
-450
-1% -$43.8K
CBL
41
DELISTED
CBL& Associates Properties, Inc.
CBL
$4.65M 0.67%
404,505
+247,685
+158% +$2.87M
CSCO icon
42
Cisco
CSCO
$450B
$4.59M 0.67%
151,957
-11,850
-7% -$361K
T icon
43
AT&T
T
$165B
$4.58M 0.66%
142,736
-3,293
-2% -$97.2K
HYG icon
44
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$4.48M 0.65%
51,732
+849
+2% +$73.1K
MO icon
45
Altria Group
MO
$122B
$4.26M 0.62%
63,037
SPG icon
46
Simon Property Group
SPG
$74.5B
$4.05M 0.59%
22,772
-341
-1% -$63.3K
IYG icon
47
iShares US Financial Services ETF
IYG
$2.13B
$3.87M 0.56%
109,269
+1,365
+1% +$44.5K
FDX icon
48
FedEx
FDX
$74.5B
$3.63M 0.53%
19,474
-90
-0.5% -$16.5K
HAIN icon
49
Hain Celestial
HAIN
$47.8M
$3.49M 0.51%
89,415
+9,600
+12% +$360K
WFC icon
50
Wells Fargo
WFC
$261B
$3.45M 0.5%
62,668
-2,168
-3% -$109K

Similar funds

Gerald L. Ray & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Gerald L. Ray & Associates held 326 positions worth $690M, up 3.5% from $667M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gerald L. Ray & Associates's Q4 2016 filing shows 10 new, 96 increased, 106 reduced and 15 closed positions. Its largest new stake was Vanguard Information Technology ETF: 42,040 shares worth $638K. The largest sale was GGP Inc., an estimated $1.11M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q4 2016 buy was Vanguard Information Technology ETF: 42,040 shares worth $638K.
  • Gerald L. Ray & Associates added most to CBL& Associates Properties, Inc. in Q4 2016, an estimated $2.87M increase.
  • Gerald L. Ray & Associates's biggest Q4 2016 reduction was Lowe's Companies, cutting an estimated $944K.
  • Gerald L. Ray & Associates fully exited GGP Inc. in Q4 2016, selling an estimated $1.11M.
  • Gerald L. Ray & Associates's ten largest holdings make up 28% of its $690M portfolio in Q4 2016.
  • Gerald L. Ray & Associates opened 10 new positions and closed 15 in Q4 2016.
  • Gerald L. Ray & Associates's portfolio value rose 3.5% quarter-over-quarter to $690M.

Based on Gerald L. Ray & Associates's 13F filing for Q4 2016, filed 7 Feb 2017.